225 related articles for article (PubMed ID: 25482938)
1. Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Booth L; Cruickshanks N; Tavallai S; Roberts JL; Peery M; Poklepovic A; Dent P
Cancer Biol Ther; 2014; 15(12):1646-57. PubMed ID: 25482938
[TBL] [Abstract][Full Text] [Related]
2. Fingolimod Augments Monomethylfumarate Killing of GBM Cells.
Dent P; Booth L; Roberts JL; Poklepovic A; Hancock JF
Front Oncol; 2020; 10():22. PubMed ID: 32047722
[TBL] [Abstract][Full Text] [Related]
3. Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Tavallai M; Booth L; Roberts JL; McGuire WP; Poklepovic A; Dent P
Oncotarget; 2016 Apr; 7(14):17290-300. PubMed ID: 26981780
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of autophagy and cell viability by ceramide species.
Cruickshanks N; Roberts JL; Bareford MD; Tavallai M; Poklepovic A; Booth L; Spiegel S; Dent P
Cancer Biol Ther; 2015; 16(5):733-42. PubMed ID: 25803131
[TBL] [Abstract][Full Text] [Related]
5. Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gα
Booth L; Roberts JL; Sander C; Lalani AS; Kirkwood JM; Hancock JF; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(5):700-710. PubMed ID: 30571927
[TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway.
Xie X; Zhao Y; Ma CY; Xu XM; Zhang YQ; Wang CG; Jin J; Shen X; Gao JL; Li N; Sun ZJ; Dong DL
Br J Pharmacol; 2015 Aug; 172(15):3929-43. PubMed ID: 25953698
[TBL] [Abstract][Full Text] [Related]
7. Valproate augments Niraparib killing of tumor cells.
Booth L; Roberts JL; Rais R; Poklepovic A; Dent P
Cancer Biol Ther; 2018; 19(9):797-808. PubMed ID: 29923797
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
9. PDE5 inhibitors enhance celecoxib killing in multiple tumor types.
Booth L; Roberts JL; Cruickshanks N; Tavallai S; Webb T; Samuel P; Conley A; Binion B; Young HF; Poklepovic A; Spiegel S; Dent P
J Cell Physiol; 2015 May; 230(5):1115-27. PubMed ID: 25303541
[TBL] [Abstract][Full Text] [Related]
10. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
[TBL] [Abstract][Full Text] [Related]
11. Experimental Investigations of Monomethyl and Dimethyl Fumarate in an Astrocyte-Microglia Co-Culture Model of Inflammation.
Corvace F; Faustmann TJ; Heckers S; Faustmann PM; Ismail FS
Pharmacology; 2023; 108(2):188-198. PubMed ID: 36724743
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
Yu XD; Wang SY; Chen GA; Hou CM; Zhao M; Hong JA; Nguyen DM; Schrump DS
Cancer J; 2007; 13(2):105-13. PubMed ID: 17476138
[TBL] [Abstract][Full Text] [Related]
13. Prior exposure of pancreatic tumors to [sorafenib + vorinostat] enhances the efficacy of an anti-PD-1 antibody.
Booth L; Roberts JL; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(1):109-121. PubMed ID: 30142009
[TBL] [Abstract][Full Text] [Related]
14. The CHK1 inhibitor SRA737 synergizes with PARP1 inhibitors to kill carcinoma cells.
Booth L; Roberts J; Poklepovic A; Dent P
Cancer Biol Ther; 2018; 19(9):786-796. PubMed ID: 30024813
[TBL] [Abstract][Full Text] [Related]
15. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
Yacoub A; Mitchell C; Hong Y; Gopalkrishnan RV; Su ZZ; Gupta P; Sauane M; Lebedeva IV; Curiel DT; Mahasreshti PJ; Rosenfeld MR; Broaddus WC; James CD; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2004 Aug; 3(8):739-51. PubMed ID: 15197348
[TBL] [Abstract][Full Text] [Related]
16. Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response.
Parodi B; Sanna A; Cedola A; Uccelli A; Kerlero de Rosbo N
Front Immunol; 2021; 12():655212. PubMed ID: 34084164
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.
Peng H; Li H; Sheehy A; Cullen P; Allaire N; Scannevin RH
J Neuroimmunol; 2016 Oct; 299():35-44. PubMed ID: 27725119
[TBL] [Abstract][Full Text] [Related]
18. Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signaling.
Mitchell C; Kabolizadeh P; Ryan J; Roberts JD; Yacoub A; Curiel DT; Fisher PB; Hagan MP; Farrell NP; Grant S; Dent P
Mol Pharmacol; 2007 Sep; 72(3):704-14. PubMed ID: 17578896
[TBL] [Abstract][Full Text] [Related]
19. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells.
Yacoub A; Liu R; Park MA; Hamed HA; Dash R; Schramm DN; Sarkar D; Dimitriev IP; Bell JK; Grant S; Farrell NP; Curiel DT; Fisher PB; Dent P
Mol Pharmacol; 2010 Feb; 77(2):298-310. PubMed ID: 19910452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
